TreeWAS – Variant ID: rs538641

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
F10.0 Acute intoxication	0.000	0.961	0.039
F10 Mental and behavioural disorders due to use of alcohol	0.000	0.962	0.038
K29.6 Other gastritis	0.000	0.963	0.037
F10.2 Dependence syndrome	0.000	0.965	0.035
F10.1 Harmful use	0.000	0.965	0.035
F10.4 Withdrawal state with delirium	0.000	0.971	0.029
F10.9 Unspecified mental and behavioural disorder	0.000	0.973	0.027
F10.8 Other mental and behavioural disorders	0.000	0.973	0.027
F10.7 Residual and late-onset psychotic disorder	0.000	0.973	0.027
F10.6 Amnesic syndrome	0.000	0.973	0.027
F10.5 Psychotic disorder	0.000	0.973	0.027
F10.3 Withdrawal state	0.000	0.977	0.023
K29 Gastritis and duodenitis	0.000	0.977	0.023
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.000	0.979	0.021
K29.5 Chronic gastritis, unspecified	0.000	0.979	0.021
K29.7 Gastritis, unspecified	0.000	0.979	0.021
F17 Mental and behavioural disorders due to use of tobacco	0.000	0.982	0.018
K29.3 Chronic superficial gastritis	0.000	0.983	0.017
K29.4 Chronic atrophic gastritis	0.000	0.983	0.016
K29.9 Gastroduodenitis, unspecified	0.000	0.984	0.016
K29.2 Alcoholic gastritis	0.000	0.984	0.016
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.000	0.984	0.015
F18 Mental and behavioural disorders due to use of volatile solvents	0.000	0.984	0.015
F16 Mental and behavioural disorders due to use of hallucinogens	0.000	0.984	0.015
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.000	0.984	0.015
F14 Mental and behavioural disorders due to use of cocaine	0.000	0.984	0.015
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.000	0.984	0.015
F12 Mental and behavioural disorders due to use of cannabinoids	0.000	0.984	0.015
F11 Mental and behavioural disorders due to use of opioids	0.000	0.984	0.015
F17.1 Harmful use	0.000	0.985	0.015
F17.2 Dependence syndrome	0.000	0.986	0.014
K29.0 Acute haemorrhagic gastritis	0.000	0.986	0.014
B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters	0.000	0.986	0.014
F17.9 Unspecified mental and behavioural disorder	0.000	0.987	0.013
F17.8 Other mental and behavioural disorders	0.000	0.987	0.013
F17.7 Residual and late-onset psychotic disorder	0.000	0.987	0.013
F17.6 Amnesic syndrome	0.000	0.987	0.013
F17.5 Psychotic disorder	0.000	0.987	0.013
F17.4 Withdrawal state with delirium	0.000	0.987	0.013
F17.3 Withdrawal state	0.000	0.987	0.013
F17.0 Acute intoxication	0.000	0.987	0.013
K29.1 Other acute gastritis	0.000	0.987	0.013
F11.9 Unspecified mental and behavioural disorder	0.000	0.989	0.011
F11.8 Other mental and behavioural disorders	0.000	0.989	0.011
F11.7 Residual and late-onset psychotic disorder	0.000	0.989	0.011
F11.6 Amnesic syndrome	0.000	0.989	0.011
F11.5 Psychotic disorder	0.000	0.989	0.011
F11.4 Withdrawal state with delirium	0.000	0.989	0.011
F11.3 Withdrawal state	0.000	0.989	0.011
F11.2 Dependence syndrome	0.000	0.989	0.011
F11.1 Harmful use	0.000	0.989	0.011
F11.0 Acute intoxication	0.000	0.989	0.011
F12.9 Unspecified mental and behavioural disorder	0.000	0.989	0.011
F12.8 Other mental and behavioural disorders	0.000	0.989	0.011
F12.7 Residual and late-onset psychotic disorder	0.000	0.989	0.011
F12.6 Amnesic syndrome	0.000	0.989	0.011
F12.5 Psychotic disorder	0.000	0.989	0.011
F12.4 Withdrawal state with delirium	0.000	0.989	0.011
F12.3 Withdrawal state	0.000	0.989	0.011
F12.2 Dependence syndrome	0.000	0.989	0.011
F12.1 Harmful use	0.000	0.989	0.011
F12.0 Acute intoxication	0.000	0.989	0.011
F13.9 Unspecified mental and behavioural disorder	0.000	0.989	0.011
F13.8 Other mental and behavioural disorders	0.000	0.989	0.011
F13.7 Residual and late-onset psychotic disorder	0.000	0.989	0.011
F13.6 Amnesic syndrome	0.000	0.989	0.011
F13.5 Psychotic disorder	0.000	0.989	0.011
F13.4 Withdrawal state with delirium	0.000	0.989	0.011
F13.3 Withdrawal state	0.000	0.989	0.011
F13.2 Dependence syndrome	0.000	0.989	0.011
F13.1 Harmful use	0.000	0.989	0.011
F13.0 Acute intoxication	0.000	0.989	0.011
F14.9 Unspecified mental and behavioural disorder	0.000	0.989	0.011
F14.8 Other mental and behavioural disorders	0.000	0.989	0.011
F14.7 Residual and late-onset psychotic disorder	0.000	0.989	0.011
F14.6 Amnesic syndrome	0.000	0.989	0.011
F14.5 Psychotic disorder	0.000	0.989	0.011
F14.4 Withdrawal state with delirium	0.000	0.989	0.011
F14.3 Withdrawal state	0.000	0.989	0.011
F14.2 Dependence syndrome	0.000	0.989	0.011
F14.1 Harmful use	0.000	0.989	0.011
F14.0 Acute intoxication	0.000	0.989	0.011
F15.9 Unspecified mental and behavioural disorder	0.000	0.989	0.011
F15.8 Other mental and behavioural disorders	0.000	0.989	0.011
F15.7 Residual and late-onset psychotic disorder	0.000	0.989	0.011
F15.6 Amnesic syndrome	0.000	0.989	0.011
F15.5 Psychotic disorder	0.000	0.989	0.011
F15.4 Withdrawal state with delirium	0.000	0.989	0.011
F15.3 Withdrawal state	0.000	0.989	0.011
F15.2 Dependence syndrome	0.000	0.989	0.011
F15.1 Harmful use	0.000	0.989	0.011
F15.0 Acute intoxication	0.000	0.989	0.011
F16.9 Unspecified mental and behavioural disorder	0.000	0.989	0.011
F16.8 Other mental and behavioural disorders	0.000	0.989	0.011
F16.7 Residual and late-onset psychotic disorder	0.000	0.989	0.011
F16.6 Amnesic syndrome	0.000	0.989	0.011
F16.5 Psychotic disorder	0.000	0.989	0.011
F16.4 Withdrawal state with delirium	0.000	0.989	0.011
F16.3 Withdrawal state	0.000	0.989	0.011
F16.2 Dependence syndrome	0.000	0.989	0.011
F16.1 Harmful use	0.000	0.989	0.011
F16.0 Acute intoxication	0.000	0.989	0.011
F18.9 Unspecified mental and behavioural disorder	0.000	0.989	0.011
F18.8 Other mental and behavioural disorders	0.000	0.989	0.011
F18.7 Residual and late-onset psychotic disorder	0.000	0.989	0.011
F18.6 Amnesic syndrome	0.000	0.989	0.011
F18.5 Psychotic disorder	0.000	0.989	0.011
F18.4 Withdrawal state with delirium	0.000	0.989	0.011
F18.3 Withdrawal state	0.000	0.989	0.011
F18.2 Dependence syndrome	0.000	0.989	0.011
F18.1 Harmful use	0.000	0.989	0.011
F18.0 Acute intoxication	0.000	0.989	0.011
F19.9 Unspecified mental and behavioural disorder	0.000	0.989	0.011
F19.8 Other mental and behavioural disorders	0.000	0.989	0.011
F19.7 Residual and late-onset psychotic disorder	0.000	0.989	0.011
F19.6 Amnesic syndrome	0.000	0.989	0.011
F19.5 Psychotic disorder	0.000	0.989	0.011
F19.4 Withdrawal state with delirium	0.000	0.989	0.011
F19.3 Withdrawal state	0.000	0.989	0.011
F19.2 Dependence syndrome	0.000	0.989	0.011
F19.1 Harmful use	0.000	0.989	0.011
F19.0 Acute intoxication	0.000	0.989	0.011
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.000	0.990	0.010
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters	0.000	0.991	0.009
K29.8 Duodenitis	0.000	0.991	0.009
Y42.5 Other oestrogens and progestogens	0.008	0.992	0.000
N81.2 Incomplete uterovaginal prolapse	0.000	0.992	0.008
B95.0 Streptococcus, group A, as the cause of diseases classified to other chapters	0.000	0.992	0.008
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.000	0.992	0.008
Y83.6 Removal of other organ (partial) (total)	0.000	0.992	0.008
B95.2 Streptococcus, group D, as the cause of diseases classified to other chapters	0.000	0.993	0.007
B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters	0.000	0.993	0.007
M41.96 Scoliosis, unspecified (Lumbar region)	0.007	0.993	0.000
B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters	0.000	0.994	0.006
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.006	0.994	0.000
B95.7 Other staphylococcus as the cause of diseases classified to other chapters	0.000	0.994	0.006
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters	0.000	0.994	0.006
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.005	0.995	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.005	0.995	0.000
I27.2 Other secondary pulmonary hypertension	0.000	0.995	0.005
Y42.9 Other and unspecified hormone antagonists	0.005	0.995	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.005	0.995	0.000
Y42.4 Oral contraceptives	0.005	0.995	0.000
Y42.2 Antithyroid drugs	0.005	0.995	0.000
Y42.1 Thyroid hormones and substitutes	0.005	0.995	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.005	0.995	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.005	0.995	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
Y57 Other and unspecified drugs and medicaments	0.005	0.995	0.000
Y44 Agents primarily affecting blood constituents	0.005	0.995	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.005	0.995	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.004	0.995	0.000
Y42.7 Androgens and anabolic congeners	0.004	0.995	0.000
K22.8 Other specified diseases of oesophagus	0.000	0.996	0.004
Y44.2 Anticoagulants	0.004	0.996	0.000
Y57.9 Drug or medicament, unspecified	0.004	0.996	0.000
I27 Other pulmonary heart diseases	0.000	0.996	0.004
K21.0 Gastro-oesophageal reflux disease with oesophagitis	0.000	0.996	0.004
I27.0 Primary pulmonary hypertension	0.000	0.996	0.004
B95-B98 Bacterial, viral and other infectious agents	0.000	0.996	0.004
M25.77 Osteophyte (Ankle and foot)	0.004	0.996	0.000
K22 Other diseases of oesophagus	0.000	0.996	0.004
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
M41.9 Scoliosis, unspecified	0.004	0.996	0.000
Y54.3 Benzothiadiazine derivatives	0.004	0.996	0.000
Y59 Other and unspecified vaccines and biological substances	0.004	0.996	0.000
Y58 Bacterial vaccines	0.004	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.004	0.996	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.004	0.996	0.000
Y48 Anaesthetics and therapeutic gases	0.004	0.996	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
M25.75 Osteophyte (Pelvic region and thigh)	0.004	0.996	0.000
Y54.5 Other diuretics	0.004	0.996	0.000
K22.7 Barrett's oesophagus	0.000	0.996	0.004
N73.6 Female pelvic peritoneal adhesions	0.000	0.996	0.004
B96.2 Escherichia coli [E. coli] as the cause of diseases classified to other chapters	0.000	0.996	0.004
Y57.5 X-ray contrast media	0.004	0.996	0.000
Y52 Agents primarily affecting the cardiovascular system	0.004	0.996	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
Y51.0 Anticholinesterase agents	0.004	0.996	0.000
M25.7 Osteophyte	0.004	0.996	0.000
Y57.8 Other drugs and medicaments	0.003	0.996	0.000
Y57.7 Vitamins, not elsewhere classified	0.003	0.996	0.000
Y57.6 Other diagnostic agents	0.003	0.996	0.000
Y57.4 Pharmaceutical excipients	0.003	0.996	0.000
Y57.3 Alcohol deterrents	0.003	0.996	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.996	0.000
Y57.1 Lipotropic drugs	0.003	0.996	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.996	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.003	0.996	0.000
Y44.7 Plasma substitutes	0.003	0.996	0.000
Y44.6 Natural blood and blood products	0.003	0.996	0.000
Y44.5 Thrombolytic drugs	0.003	0.996	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.003	0.996	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.996	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.003	0.996	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.003	0.996	0.000
B96 Other bacterial agents as the cause of diseases classified to other chapters	0.000	0.996	0.004
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.996	0.000
Y54.9 Mineral salts, not elsewhere classified	0.003	0.996	0.000
Y54.8 Agents affecting uric acid metabolism	0.003	0.996	0.000
Y54.7 Agents affecting calcification	0.003	0.996	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.996	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.996	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.996	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.003	0.996	0.000
Y54.0 Mineralocorticoids	0.003	0.996	0.000
I26.9 Pulmonary embolism without mention of acute cor pulmonale	0.000	0.996	0.004
K22.6 Gastro-oesophageal laceration-haemorrhage syndrome	0.000	0.996	0.003
K22.2 Oesophageal obstruction	0.000	0.996	0.003
N73.9 Female pelvic inflammatory disease, unspecified	0.000	0.997	0.003
I27.9 Pulmonary heart disease, unspecified	0.000	0.997	0.003
I27.8 Other specified pulmonary heart diseases	0.000	0.997	0.003
I27.1 Kyphoscoliotic heart disease	0.000	0.997	0.003
K22.5 Diverticulum of oesophagus, acquired	0.000	0.997	0.003
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
K20-K31 Diseases of oesophagus, stomach and duodenum	0.000	0.997	0.003
M25.72 Osteophyte (Upper arm)	0.003	0.997	0.000
N73 Other female pelvic inflammatory diseases	0.000	0.997	0.003
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters	0.000	0.997	0.003
K22.9 Disease of oesophagus, unspecified	0.000	0.997	0.003
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
F31.9 Bipolar affective disorder, unspecified	0.000	0.997	0.003
K22.3 Perforation of oesophagus	0.000	0.997	0.003
I26 Pulmonary embolism	0.000	0.997	0.003
K21 Gastro-oesophageal reflux disease	0.000	0.997	0.003
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.5 Other antipsychotics and neuroleptics	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M41.97 Scoliosis, unspecified (Lumbosacral region)	0.003	0.997	0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.003	0.997	0.000
M41.94 Scoliosis, unspecified (Thoracic region)	0.003	0.997	0.000
M41.93 Scoliosis, unspecified (Cervicothoracic region)	0.003	0.997	0.000
M41.92 Scoliosis, unspecified (Cervical region)	0.003	0.997	0.000
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)	0.003	0.997	0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.003	0.997	0.000
K22.1 Ulcer of oesophagus	0.000	0.997	0.003
B98 Other specified infectious agents as the cause of diseases classified to other chapters	0.000	0.997	0.003
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
Y46.6 Other and unspecified antiepileptics	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.4 Iminostilbenes	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.2 Hydantoin derivatives	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.997	0.000
Y47.4 Bromine compounds	0.003	0.997	0.000
Y47.3 Paraldehyde	0.003	0.997	0.000
Y47.2 Chloral derivatives	0.003	0.997	0.000
Y47.1 Benzodiazepines	0.003	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
Y48.3 Local anaesthetics	0.003	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
Y50.9 Central nervous system stimulant, unspecified	0.003	0.997	0.000
Y50.8 Other central nervous system stimulants	0.003	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.003	0.997	0.000
Y50.1 Opioid receptor antagonists	0.003	0.997	0.000
Y50.0 Analeptics	0.003	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.4 Other laxatives	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
Y55.5 Anticommon cold drugs	0.003	0.997	0.000
Y55.4 Expectorants	0.003	0.997	0.000
Y55.3 Antitussives	0.003	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
Y55.0 Oxytocic drugs	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.003	0.997	0.000
Y56.8 Other topical agents	0.003	0.997	0.000
Y56.7 Dental drugs, topically applied	0.003	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
Y56.2 Local astringents and local detergents	0.003	0.997	0.000
Y56.1 Antipruritics	0.003	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.003	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.003	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.003	0.997	0.000
Y58.5 Diphtheria vaccine	0.003	0.997	0.000
Y58.4 Tetanus vaccine	0.003	0.997	0.000
Y58.3 Plague vaccine	0.003	0.997	0.000
Y58.2 Cholera vaccine	0.003	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.003	0.997	0.000
Y58.0 BCG vaccine	0.003	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.003	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.003	0.997	0.000
Y59.3 Immunoglobulin	0.003	0.997	0.000
Y59.2 Protozoal vaccines	0.003	0.997	0.000
Y59.1 Rickettsial vaccines	0.003	0.997	0.000
Y59.0 Viral vaccines	0.003	0.997	0.000
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)	0.003	0.997	0.000
K27 Peptic ulcer, site unspecified	0.000	0.997	0.003
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.003	0.997	0.000
Y43 Primarily systemic agents	0.003	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.000	0.997	0.003
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
B96.4 Proteus (mirabilis)(morganii) as the cause of diseases classified to other chapters	0.000	0.997	0.003
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.997	0.003
M25.6 Stiffness of joint, not elsewhere classified	0.003	0.997	0.000
M25.79 Osteophyte (Site unspecified)	0.003	0.997	0.000
M25.73 Osteophyte (Forearm)	0.003	0.997	0.000
M25.70 Osteophyte (Multiple sites)	0.003	0.997	0.000
B97 Viral agents as the cause of diseases classified to other chapters	0.000	0.997	0.003
C19 Malignant neoplasm of rectosigmoid junction	0.000	0.997	0.003
B96.7 Clostridium perfringens [C. perfringens] as the cause of diseases classified to other chapters	0.000	0.997	0.003
B96.6 Bacillus fragilis [B. fragilis] as the cause of diseases classified to other chapters	0.000	0.997	0.003
B96.0 Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified to other chapters	0.000	0.997	0.003
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
Y41.5 Antiviral drugs	0.003	0.997	0.000
Y41.4 Anthelminthics	0.003	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.003	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
Y41.1 Antimycobacterial drugs	0.003	0.997	0.000
Y41.0 Sulphonamides	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters	0.000	0.997	0.003
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
M25.71 Osteophyte (Shoulder region)	0.003	0.997	0.000
O20.0 Threatened abortion	0.003	0.997	0.000
W20-W49 Exposure to inanimate mechanical forces	0.003	0.997	0.000
C15.5 Lower third of oesophagus	0.000	0.997	0.003
H50.9 Strabismus, unspecified	0.003	0.997	0.000
M25.76 Osteophyte (Lower leg)	0.003	0.997	0.000
M25.74 Osteophyte (Hand)	0.003	0.997	0.000
K22.0 Achalasia of cardia	0.000	0.997	0.002
K28 Gastrojejunal ulcer	0.000	0.997	0.003
K23 Disorders of oesophagus in diseases classified elsewhere	0.000	0.997	0.003
Chapter XX External causes of morbidity and mortality	0.003	0.997	0.000
Y45.1 Salicylates	0.003	0.997	0.000
M25.66 Stiffness of joint, not elsewhere classified (Lower leg)	0.003	0.997	0.000
N73.8 Other specified female pelvic inflammatory diseases	0.000	0.997	0.002
N73.5 Female pelvic peritonitis, unspecified	0.000	0.997	0.002
N73.4 Female chronic pelvic peritonitis	0.000	0.997	0.002
N73.3 Female acute pelvic peritonitis	0.000	0.997	0.002
N73.2 Unspecified parametritis and pelvic cellulitis	0.000	0.997	0.002
N73.1 Chronic parametritis and pelvic cellulitis	0.000	0.997	0.002
N73.0 Acute parametritis and pelvic cellulitis	0.000	0.997	0.002
I26.0 Pulmonary embolism with mention of acute cor pulmonale	0.000	0.997	0.002
M41 Scoliosis	0.002	0.997	0.000
B98.1 Vibrio vulnificus as the cause of diseases classified to other chapters	0.000	0.997	0.002
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.997	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.997	0.000
W23 Caught, crushed, jammed or pinched in or between objects	0.002	0.997	0.000
Z80.3 Family history of malignant neoplasm of breast	0.002	0.997	0.000
Z86.5 Personal history of other mental and behavioural disorders	0.000	0.997	0.003
W22 Striking against or struck by other objects	0.002	0.997	0.000
K27.7 Chronic without haemorrhage or perforation	0.000	0.998	0.002
K27.6 Chronic or unspecified with both haemorrhage and perforation	0.000	0.998	0.002
K27.5 Chronic or unspecified with perforation	0.000	0.998	0.002
K27.4 Chronic or unspecified with haemorrhage	0.000	0.998	0.002
K27.3 Acute without haemorrhage or perforation	0.000	0.998	0.002
K27.2 Acute with both haemorrhage and perforation	0.000	0.998	0.002
K27.1 Acute with perforation	0.000	0.998	0.002
K27.0 Acute with haemorrhage	0.000	0.998	0.002
K62.8 Other specified diseases of anus and rectum	0.000	0.998	0.002
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
Y45.4 Antirheumatics	0.002	0.998	0.000
N70.1 Chronic salpingitis and oophoritis	0.000	0.998	0.002
M25 Other joint disorders, not elsewhere classified	0.002	0.998	0.000
V10-V19 Pedal cyclist injured in transport accident	0.002	0.998	0.000
M25.67 Stiffness of joint, not elsewhere classified (Ankle and foot)	0.002	0.998	0.000
M41.99 Scoliosis, unspecified (Site unspecified)	0.002	0.998	0.000
Y84.8 Other medical procedures	0.002	0.998	0.000
M25.64 Stiffness of joint, not elsewhere classified (Hand)	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
I28 Other diseases of pulmonary vessels	0.000	0.998	0.002
Y60-Y69 Misadventures to patients during surgical and medical care	0.002	0.998	0.000
W50-W64 Exposure to animate mechanical forces	0.002	0.998	0.000
M25.78 Osteophyte (Other)	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
Y40.6 Rifamycins	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
W23.2 School, other institution and public administrative area	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
M25.69 Stiffness of joint, not elsewhere classified (Site unspecified)	0.002	0.998	0.000
M25.68 Stiffness of joint, not elsewhere classified (Other)	0.002	0.998	0.000
M25.65 Stiffness of joint, not elsewhere classified (Pelvic region and thigh)	0.002	0.998	0.000
M25.63 Stiffness of joint, not elsewhere classified (Forearm)	0.002	0.998	0.000
M25.62 Stiffness of joint, not elsewhere classified (Upper arm)	0.002	0.998	0.000
M25.60 Stiffness of joint, not elsewhere classified (Multiple sites)	0.002	0.998	0.000
W25 Contact with sharp glass	0.002	0.998	0.000
B97.6 Parvovirus as the cause of diseases classified to other chapters	0.000	0.998	0.002
B97.5 Reovirus as the cause of diseases classified to other chapters	0.000	0.998	0.002
B97.4 Respiratory synctial virus as the cause of diseases classified to other chapters	0.000	0.998	0.002
B97.3 Retrovirus as the cause of diseases classified to other chapters	0.000	0.998	0.002
B97.2 Coronavirus as the cause of diseases classified to other chapters	0.000	0.998	0.002
B97.1 Enterovirus as the cause of diseases classified to other chapters	0.000	0.998	0.002
B97.0 Adenovirus as the cause of diseases classified to other chapters	0.000	0.998	0.002
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.000	0.998	0.002
W22.9 Unspecified place	0.002	0.998	0.000
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.002	0.998	0.000
N88.8 Other specified noninflammatory disorders of cervix uteri	0.000	0.998	0.002
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.002	0.998	0.000
W44 Foreign body entering into or through eye or natural orifice	0.002	0.998	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.000	0.998	0.002
X20-X29 Contact with venomous animals and plants	0.002	0.998	0.000
M25.81 Other specified joint disorders (Shoulder region)	0.002	0.998	0.000
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.000	0.998	0.002
Y60.0 During surgical operation	0.002	0.998	0.000
V19 Pedal cyclist injured in other and unspecified transport accidents	0.002	0.998	0.000
W49 Exposure to other and unspecified inanimate mechanical forces	0.002	0.998	0.000
W46 Contact with hypodermic needle	0.002	0.998	0.000
W45 Foreign body or object entering through skin	0.002	0.998	0.000
W43 Exposure to vibration	0.002	0.998	0.000
W42 Exposure to noise	0.002	0.998	0.000
W41 Exposure to high-pressure jet	0.002	0.998	0.000
W40 Explosion of other materials	0.002	0.998	0.000
W39 Discharge of firework	0.002	0.998	0.000
W38 Explosion and rupture of other specified pressurised devices	0.002	0.998	0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose	0.002	0.998	0.000
W36 Explosion and rupture of gas cylinder	0.002	0.998	0.000
W35 Explosion and rupture of boiler	0.002	0.998	0.000
W34 Discharge from other and unspecified firearms	0.002	0.998	0.000
W33 Rifle, shotgun and larger firearm discharge	0.002	0.998	0.000
W32 Handgun discharge	0.002	0.998	0.000
W31 Contact with other and unspecified machinery	0.002	0.998	0.000
W30 Contact with agricultural machinery	0.002	0.998	0.000
W28 Contact with powered lawn mower	0.002	0.998	0.000
W27 Contact with nonpowered hand tool	0.002	0.998	0.000
W26 Contact with knife, sword or dagger	0.002	0.998	0.000
W24 Contact with lifting and transmission devices, not elsewhere classified	0.002	0.998	0.000
W21 Striking against or struck by sports equipment	0.002	0.998	0.000
W20 Struck by thrown, projected or falling object	0.002	0.998	0.000
M25.8 Other specified joint disorders	0.002	0.998	0.000
W29 Contact with other powered hand tools and household machinery	0.002	0.998	0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.002	0.998	0.000
Y00-Y09 Assault	0.002	0.998	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	0.000	0.998	0.002
K22.4 Dyskinesia of oesophagus	0.000	0.998	0.002
F31 Bipolar affective disorder	0.000	0.998	0.002
X50-X57 Overexertion, travel and privation	0.002	0.998	0.000
W55 Bitten or struck by other mammals	0.002	0.998	0.000
K23.8 Disorders of oesophagus in other diseases classified elsewhere	0.000	0.998	0.002
K23.1 Megaoesophagus in Chagas' disease	0.000	0.998	0.002
K23.0 Tuberculous oesophagitis	0.000	0.998	0.002
K28.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.998	0.002
K28.7 Chronic without haemorrhage or perforation	0.000	0.998	0.002
K28.6 Chronic or unspecified with both haemorrhage and perforation	0.000	0.998	0.002
K28.5 Chronic or unspecified with perforation	0.000	0.998	0.002
K28.4 Chronic or unspecified with haemorrhage	0.000	0.998	0.002
K28.3 Acute without haemorrhage or perforation	0.000	0.998	0.002
K28.2 Acute with both haemorrhage and perforation	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations